Ontology highlight
ABSTRACT:
SUBMITTER: Villalobos P
PROVIDER: S-EPMC5137804 | biostudies-other | 2017 Feb
REPOSITORIES: biostudies-other
Villalobos Pamela P Wistuba Ignacio I II
Hematology/oncology clinics of North America 20170201 1
The molecular characterization of lung cancer has changed the classification and treatment of these tumors, becoming an essential component of pathologic diagnosis and oncologic therapy decisions. Through the recognition of novel biomarkers, such as epidermal growth factor receptor mutations and anaplastic lymphoma kinase translocations, it is possible to identify subsets of patients who benefit from targeted molecular therapies. The success of targeted anticancer therapies and new immunotherapy ...[more]